Shield Therapeutics PLC (AIM:STX, OTCQX:SHIEF) s third-quarter trading update for Accrufer in the US market shows its tie-up with Viatris and expanded sales.
Shield Therapeutics plc (LON:STX – Get Free Report)’s stock price crossed below its 50-day moving average during trading on Thursday . The stock has a 50-day moving average of GBX 6.32 ($0.08) and traded as low as GBX 6.25 ($0.08). Shield Therapeutics shares last traded at GBX 6.55 ($0.08), with a volume of 13,253,598 shares. […]